In connection with the Agreement and Plan of Merger and Reorganization by and among Graybug Vision, Inc. and CalciMedica, Inc., a Delaware corporation, and additional parties thereto, which is included as Exhibit 2.1 to Current Report on Form 8-K filed with the Securities and Exchange Commission (the Commission") on November 22, 2022, on February 5, 2023, the Board of Directors (the Board") of the Company together with the Compensation Committee of the Board (the Compensation Committee") and the Nominating and Corporate Governance Committee of the Board (the Governance Committee"), unanimously approved the appointment of A. Rachel Leheny, Ph.D., Eric W. Roberts, Robert N. Wilson, Fred Middleton and Allan Shaw, aged 59, 59, 82, 73 and 58, respectively, to serve as members of the Board, contingent upon the Closing and effective as of the Effective Time, in each case as defined in the Merger Agreement. In addition, the Board received letters from Christy Shaffer, Ph.D., Christina Ackermann, Julie Eastland and Dirk Sauer, Ph.D., resigning as directors of the Company and as members of the Committees of the Board, contingent upon the Closing and effective as of the Effective Time. Furthermore, Eric Bjerkholt, a current Class II member of the Board, submitted a letter to resign from the Board and was re-appointed as a Class I director, in each case, contingent upon the Closing and effective as of the Effective Time.